Publications by authors named "Jonathan Kasper"

Claim this Profile
R
Real-World Outcomes of the 0.19 mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema.
Christine Morozova, Lucas L Humayun, Jonathan Kasper, Andy Morozov, Homayoun Tabandeh

J Vitreoretin Dis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular, Visual, and Anatomical Outcomes in Eyes Requiring Incisional Intraocular Pressure-Lowering Surgery Following the 0.19-mg Fluocinolone Acetonide Intravitreal Implant.
David Eichenbaum, Victor H Gonzalez, Daniel Roth, Jorge Fortun, Nathan M Radcliffe, Jonathan Kasper

Ophthalmic Surg Lasers Imaging Retina· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Control of Retinal Thickness Variability and Vision Following the 0.19 mg Fluocinolone Acetonide Implant.
Veeral S Sheth, Michael Singer, Mathew MacCumber, Antonio Cutino, Jonathan Kasper

J Vitreoretin Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA.
Victor H Gonzalez, Caesar Luo, David R P Almeida, Antonio Cutino, Brandon Coughlin, Jonathan Kasper

Retina· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23].
Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian

Am J Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema.
Pauline T Merrill, Nancy Holekamp, Daniel Roth, Jonathan Kasper, Ruben Grigorian

Am J Ophthalmol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantification of Mitochondrial Oxidative Phosphorylation in Metabolic Disease: Application to Type 2 Diabetes.
Matthew T Lewis, Jonathan D Kasper, Jason N Bazil, Jefferson C Frisbee, Robert W Wiseman

Int J Mol Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Skeletal muscle energetics are compromised only during high-intensity contractions in the Goto-Kakizaki rat model of type 2 diabetes.
Matthew T Lewis, Jonathan D Kasper, Jason N Bazil, Jefferson C Frisbee, Robert W Wiseman

Am J Physiol Regul Integr Comp Physiol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus in the Goto-Kakizaki rat impairs microvascular function and contributes to premature skeletal muscle fatigue.
Jefferson C Frisbee, Matthew T Lewis, Jonathan D Kasper, Paul D Chantler, Robert W Wiseman

J Appl Physiol (1985)· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of altered pyruvate dehydrogenase activity on contracting skeletal muscle bioenergetics.
Jonathan D Kasper, Ronald A Meyer, Daniel A Beard, Robert W Wiseman

Am J Physiol Regul Integr Comp Physiol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Library of Fluorinated Electrophiles for Chemical Tagging and Materials Synthesis.
Jonathan J Kasper, Jamie E Hitro, Sabrina R Fitzgerald, Joseph M Schnitter, James J Rutowski

J Org Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis